Conservative surgery for Stage I ovarian carcinoma in women of childbearing age
Open Access
- 1 September 1997
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 104 (9) , 1030-1035
- https://doi.org/10.1111/j.1471-0528.1997.tb12062.x
Abstract
Objective To assess the results of a policy of tailored conservative surgical management for young women with stage I ovarian carcinomas. Design Retrospective study. Participants Ninety‐nine women aged 40 years or younger who underwent either primary surgery in our department or were referred after primary surgery performed elsewhere. Methods Of the 99 women in our study, 56 underwent fertility‐sparing surgery and 43 more radical surgery. Minimal requirements for conservative management were adequate staging and complete information about the therapeutic options. Factors important in the choice of the treatment were, age, wish to preserve fertility, histologic type and grade, and the stage of the tumour. Results Conservative treatment was conducted in 84% of nulliparous and in 33% of parous women; 62% of grade 1 tumours, 48% of grade 2, and 50% of grade 3 were treated conservatively. With a median follow up of seven years, we observed five recurrences (9%) of carcinoma in women treated conservatively and five (12%) in those treated more radically. Two women (one in each treatment arm) were saved after recurrence. Two recurrences after conservative surgery involved the residual ovary (3.6%). Two women developed borderline tumour in the contralateral ovary and both were treated by surgery. Conclusion After adequate staging and accurate information is given to the patient, conservative treatment may be safe in some women with early ovarian cancer. The risk of recurrence in the contralateral ovary is low. Conservative surgery may be also considered in some Stage I grade 3 tumours and in some women with stage IC tumours.Keywords
This publication has 14 references indexed in Scilit:
- Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)Annals of Oncology, 1995
- Controversial Issues in the Management of Early Epithelial Ovarian Cancer: Conservative Surgery and Role of Adjuvant TherapyGynecologic Oncology, 1994
- Pathology of Epithelial Ovarian TumorsClinical Obstetrics and Gynecology, 1994
- Ultrasound in the follow-up of young patients with malignant ovarian tumors after conservative surgeryUltrasound in Obstetrics & Gynecology, 1994
- Ovarian cancer stages I and II: Predictions and 5-year survival in two decadesGynecologic Oncology, 1989
- Preservation of ovarian function and reproductive ability in patients with malignant ovarian tumorsGynecologic Oncology, 1988
- Erhaltung der Ovarialfunktion in der Behandlung der epithelialen und speziellen (anderen) malignen OvarialtumorenGeburtshilfe und Frauenheilkunde, 1987
- Retroperitoneal metastases from ovarian carcinoma: reassessment of 365 patients studied with lymphographyAmerican Journal of Roentgenology, 1980
- Cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970
- Is conservative therapy ever justified in Stage I (IA) cancer of the ovary?American Journal of Obstetrics and Gynecology, 1969